Enzyme-linked immunosorbent assay method for detection of cytomegalovirus strain-specific antibody responses

Clinical and Vaccine Immunology

Volumn 16, Issue 2, 2009, Pages 288-290

  Novak, Zdenek ^a,c   Ross, Shannon A ^a   Patro, Raj Kumar ^b   Pati, Sunil Kumar ^b   Reddy, Meera K ^a   Purser, Misty ^a   Britt, William J ^a   Boppana, Suresh B ^a  

^a University of Alabama at Birmingham   (United States)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REINFECTION; RELIABILITY; VIRUS IDENTIFICATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, B-LYMPHOCYTE; HUMANS; MOLECULAR SEQUENCE DATA; VIRAL ENVELOPE PROTEINS;

EID: 59649123877     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00281-08     Document Type: Article

References (18)

1. Boppana, S. B., L. B. Rivera, K. B. Fowler, M. Mach, and W. J. Britt. 2001. Intrauterine transmission of cytomegalovirus to infants of women with pre-conceptional immunity. N. Engl. J. Med. 344:1366-1371.
2. Chou, S. 1992. Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus. Virology 188:388-390.
3. Coaquette, A., A. Bourgeois, C. Dirand, A. Varin, W. Chen, and G. Herbein. 2004. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin. Infect. Dis. 39:155-161.
4. Coonrod, D., A. C. Collier, R. Ashley, T. DeRouen, and L. Corey. 1998.Association between cytomegalovirus seroconversion and upper genital tract infection among women attending a sexually transmitted disease clinic: a prospective study. J. Infect. Dis. 177:1188-1193.
5. Dar, L., S. K. Pati, A. R. Patro, A. K. Deorari, S. Rai, S. Kant, S. Broor, K. B. Fowler, W. J. Britt, and S. B. Boppana. 2008. Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India. Pediatr.Infect. Dis. J. 27:841-843.
6. Ishibashi, K., T. Tokumoto, K. Tanabe, H. Shirakawa, K. Hashimoto, N. Kushida, T. Yanagida, N. Inoue, O. Yamaguchi, H. Toma, and T. Suzutani. 2007. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes. Clin.Infect. Dis. 45:60-67.
7. Kilpatrick, B. A., E. S. Huang, and J. S. Pagano. 1976. Analysis of cytomeg-alovirus genomes with restriction endonucleases Hin D III and EcoR-1. J. Virol. 18:1095-1105.
8. Kropff, B., M. P. Landini, and M. Mach. 1993. An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomeg-alovirus. J. Med. Virol. 39:187-195.
9. Meyer, H., V. A. Sundqvist, L. Pereira, and M. Mach. 1992. Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies. J. Gen. Virol. 73(Pt 9):2375-2383.
10. Novak, Z., S. A. Ross, R. K. Patro, S. K. Pati, R. A. Kumbla, S. Brice, and S. B. Boppana. 2008. Cytomegalovirus strain diversity in seropositive women. J. Clin. Microbiol. 46:882-886.
11. Pignatelli, S., P. Dal Monte, and M. P. Landini. 2001. gpUL73 (gN) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes. J. Gen. Virol. 82:2777-2784.
12. Pignatelli, S., P. Dal Monte, G. Rossini, and M. P. Landini. 2004. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev. Med. Virol. 14:383-410.
13. Rasmussen, L., A. Geissler, and M. Winters. 2003. Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovi-rus. J. Infect. Dis. 187:809-819.
14. Rasmussen, L., C. Hong, D. Zipeto, S. Morris, D. Sherman, S. Chou, R. Miner, W. L. Drew, R. Wolitz, A. Dowling, A. Warford, and T. C. Merigan. 1997. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J. Infect. Dis. 175:179-184.
15. Ross, S. A., Z. Novak, G. Ashrith, L. B. Rivera, W. J. Britt, S. Hedges, J. R.Schwebke, and A. S. Boppana. 2005. Association between genital tract cy-tomegalovirus infection and bacterial vaginosis. J. Infect. Dis. 192:1727-1730.
16. Urban, M., W. Britt, and M. Mach. 1992. The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific. J. Virol. 66:1303-1311.
17. van der Sande, M. A., S. Kaye, D. J. Miles, P. Waight, D. J. Jeffries, O. O. Ojuola, M. Palmero, M. Pinder, J. Ismaili, K. L. Flanagan, A. A. Aveika, A. Zaman, S. Rowland-Jones, S. J. McConkey, H. C. Whittle, and A. Marchant. 2007. Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS One 2:e492.
18. Yamamoto, A. Y., M. M. Mussi-Pinhata, L. J. Marin, R. M. Brito, P. F. Oliveira, and T. B. Coelho. 2006. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection? J. Clin. Virol. 36:228-230.